Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD

This study has been completed.
Sponsor:
Collaborator:
Bayer
Information provided by (Responsible Party):
Regeneron Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00320775
First received: April 28, 2006
Last updated: March 16, 2015
Last verified: March 2015